The brief
- Neko raised $700 million Series C in July 2026 at about $7 billion valuation, led by Lightspeed Venture Partners.
- The 60-minute full-body scan captures millions of data points on skin and cardiovascular systems, analyzed with AI.
- Over 100,000 scans completed in Sweden; first U.S. clinic opened in Manhattan in September 2026.
Technical approach
Multi-modal sensor imaging
Advanced optical sensors capture high-resolution data on skin texture and blood vessel health without radiation or needles.
AI-powered data interpretation
Machine learning models analyze scan data to identify biomarkers of disease risk, aging rate, and health status.
Connected health feedback
Scan results integrate with health apps and physician records, enabling users to track changes and detect early warning signs.
